Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid vs nanotransamic acid mouthwash for spontaneous oral bleeding in leukemia patients
IRCT20230104057046N2Phase 3Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of tranexamic acid (2 arms), sponsored by Golestan University of Medical Sciences. Primary endpoints: Bleeding frequency, Presence of bleeding and 1 more. Started Mar 2023; status: completed.
02
Drugs
tranexamic acid
Beyond the preview
Go deeper on IRCT20230104057046N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230104057046N2.